Key Financial Data Of Group

OncoTherapy Science, Inc. - Filing #7720896

Concept As at
2018-06-30
2018-04-01 to
2018-06-30
2017-04-01 to
2018-03-31
As at
2018-03-31
As at
2017-06-30
2017-04-01 to
2017-06-30
Key financial data of group
Business results of group
Ordinary profit (loss)
-717,416,000 JPY
-2,977,177,000 JPY
-590,071,000 JPY
Profit (loss) attributable to owners of parent
-647,106,000 JPY
-2,851,092,000 JPY
-568,243,000 JPY
Comprehensive income
-700,029,000 JPY
-2,927,183,000 JPY
-568,750,000 JPY
Net assets
6,861,630,000 JPY
7,579,839,000 JPY
9,514,271,000 JPY
Total assets
7,219,457,000 JPY
8,021,524,000 JPY
9,918,879,000 JPY
Basic earnings (loss) per share
-4.40
-19.39
-3.86
Diluted earnings per share
Equity-to-asset ratio
0.877 xbrli:pure
0.870 xbrli:pure
0.921 xbrli:pure

Talk to a Data Expert

Have a question? We'll get back to you promptly.